PeptiDream Inc.
4587.TJapan
16 filed reports · 433 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Latest half year
Filed reports
16 reports · Dec 2021 to Sep 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · annual securities reportEDINET | 3 | 1,183 | Dec 2021 to Dec 2025 |
| Half Year · half-year securities reportEDINET | 3 | 640 | Jun 2024 to Jun 2026 |
| Annual · amended annual securities reportEDINET | 2 | 627 | Dec 2022 to Dec 2023 |
| Q1 · quarterly securities reportEDINET | 2 | 438 | Mar 2022 to Mar 2024 |
| Q3 · quarterly securities reportEDINET | 2 | 523 | Sep 2022 to Sep 2023 |
| Half Year · amended quarterly securities reportEDINET | 1 | 229 | Jun 2023 |
| Half Year · quarterly securities reportEDINET | 1 | 203 | Jun 2022 |
| Q1 · amended quarterly securities reportEDINET | 1 | 155 | Mar 2023 |
| Q3 · quarterly earnings release (kessan tanshin)EDINET | 1 | 237 | Sep 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | quarterly earnings release (kessan tanshin) | 2026-09-30 | 2026-11-11 | 237 | Open |
| FY2026 H1 | half-year securities report | 2026-06-30 | 2026-08-12 | 269 | Open |
| FY2025 | annual securities report | 2025-12-31 | 2026-03-18 | 649 | Open |
| FY2025 H1 | half-year securities report | 2025-06-30 | 2025-08-07 | 187 | Open |
| FY2024 | annual securities report | 2024-12-31 | 2025-03-28 | 339 | Open |
| FY2024 H1 | half-year securities report | 2024-06-30 | 2024-08-09 | 184 | Open |
| FY2024 Q1 | quarterly securities report | 2024-03-31 | 2024-05-15 | 265 | Open |
| FY2023 | amended annual securities report | 2023-12-31 | 2024-09-25 | 328 | Open |
| FY2023 Q3 | quarterly securities report | 2023-09-30 | 2023-11-10 | 321 | Open |
| FY2023 H1 | amended quarterly securities report | 2023-06-30 | 2023-11-09 | 229 | Open |
| FY2023 Q1 | amended quarterly securities report | 2023-03-31 | 2023-11-09 | 155 | Open |
| FY2022 | amended annual securities report | 2022-12-31 | 2023-07-18 | 299 | Open |
Financial data
433 concepts · 4,235 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS222 concepts · 3,220 facts · Dec 2020 to Sep 2026
- Cash and Equivalents38 · Dec 2020 to Sep 2026
- Comprehensive Income Attributable to Owners of Parent37 · Mar 2021 to Sep 2026
- EPS (Basic)37 · Mar 2021 to Sep 2026
- EPS (Diluted)37 · Mar 2021 to Sep 2026
- Net Income37 · Mar 2021 to Sep 2026
- Pretax Income37 · Mar 2021 to Sep 2026
- Profit Attributable to Owners of Parent37 · Mar 2021 to Sep 2026
- Revenue37 · Mar 2021 to Sep 2026
- Total Comprehensive Income37 · Mar 2021 to Sep 2026
- Stockholders Equity36 · Dec 2020 to Sep 2026
- Equity Attributable to Owners of Parent35 · Dec 2020 to Sep 2026
- Total Assets35 · Dec 2020 to Sep 2026
- Capital surplus (IFRS)31 · Dec 2020 to Sep 2026
- Financing Cash Flow31 · Mar 2021 to Sep 2026
- Intangible assets (IFRS)31 · Dec 2020 to Sep 2026
- Inventory31 · Dec 2020 to Sep 2026
- Investing Cash Flow31 · Mar 2021 to Sep 2026
- Operating Cash Flow31 · Mar 2021 to Sep 2026
- Other components of equity31 · Dec 2020 to Sep 2026
- Other current assets - CA (IFRS)31 · Dec 2020 to Sep 2026
- Other current liabilities - CL (IFRS)31 · Dec 2020 to Sep 2026
- Other financial assets - CA (IFRS)31 · Dec 2020 to Sep 2026
- Other financial assets - NCA (IFRS)31 · Dec 2020 to Sep 2026
- Other non-current assets - NCA (IFRS)31 · Dec 2020 to Sep 2026
GAAP195 concepts · 776 facts · Dec 2019 to Dec 2025
- EPS (Basic)8 · Dec 2019 to Dec 2025
- Equity-to-asset ratio, Key financial data8 · Dec 2019 to Dec 2025
- Net Assets8 · Dec 2019 to Dec 2025
- Net assets per share8 · Dec 2019 to Dec 2025
- Ordinary profit (loss), Key financial data8 · Dec 2019 to Dec 2025
- Revenue8 · Dec 2019 to Dec 2025
- Total Assets8 · Dec 2019 to Dec 2025
- Net assets, Key financial data7 · Dec 2019 to Dec 2025
- Net Income7 · Dec 2019 to Dec 2025
- Number of employees7 · Dec 2019 to Dec 2025
- Rate of return on equity, Key financial data7 · Dec 2020 to Dec 2025
- Share capital, Key financial data7 · Dec 2019 to Dec 2025
- Total number of issued shares7 · Dec 2019 to Dec 2025
- Accounts payable - other6 · Dec 2020 to Dec 2025
- Accounts payable - trade6 · Dec 2020 to Dec 2025
- Accounts receivable - trade6 · Dec 2020 to Dec 2025
- Accrued expenses6 · Dec 2020 to Dec 2025
- Accumulated depreciation-buildings6 · Dec 2020 to Dec 2025
- Accumulated depreciation-structures6 · Dec 2020 to Dec 2025
- Accumulated depreciation-tools, furniture and fixtures6 · Dec 2020 to Dec 2025
- Advances received6 · Dec 2020 to Dec 2025
- Buildings6 · Dec 2020 to Dec 2025
- Buildings, net6 · Dec 2020 to Dec 2025
- Capital surplus6 · Dec 2020 to Dec 2025
Segment12 concepts · 231 facts · Dec 2021 to Sep 2026
- Revenue61 · Jun 2022 to Sep 2026
- Revenue from external customers (IFRS)47 · Jun 2022 to Sep 2026
- Segment profit (loss)47 · Jun 2022 to Sep 2026
- Intersegment revenue (IFRS)42 · Sep 2022 to Sep 2026
- Number of employees13 · Dec 2021 to Dec 2025
- Depreciation and amortization - Operating expenses (IFRS)9 · Dec 2023 to Dec 2025
- Business combination-related expenses2 · Sep 2025 to Sep 2026
- Finance costs (IFRS)2 · Sep 2025 to Sep 2026
- Finance income (IFRS)2 · Sep 2025 to Sep 2026
- Operating Income2 · Sep 2025 to Sep 2026
- Pretax Income2 · Sep 2025 to Sep 2026
- Share of profit (loss) of investments accounted for using equity method2 · Sep 2025 to Sep 2026
Guidance4 concepts · 8 facts · Nov 2026
- Operating Income Guidance2 · Nov 2026
- Pretax Income Guidance2 · Nov 2026
- Profit Attributable to Owners of Parent Guidance2 · Nov 2026
- Revenue Guidance2 · Nov 2026
Segments
231 factsFigures broken down by business line, region, product or another axis the company reports on.
Operating segments6 members · 231 facts
- RadiopharmaceuticalsBusinessReportableSegmentMember66 · Jun 2022 to Sep 2026
- ReportableSegmentsMember62 · Jun 2022 to Sep 2026
- DrugDiscoveryAndDevelopmentBusinessReportableSegmentMember52 · Jun 2022 to Sep 2026
- ReconcilingItemsMember28 · Sep 2022 to Sep 2026
- EntityTotalMember18 · Sep 2025 to Sep 2026
- CorporateSharedMember5 · Dec 2021 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of PeptiDream Inc. (4587.T) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.